Maridea Wealth Management LLC Acquires New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Maridea Wealth Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 1,392 shares of the healthcare conglomerate's stock, valued at approximately $704,000.

A number of other institutional investors have also modified their holdings of UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $32,000. Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $40,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group in the third quarter valued at approximately $57,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH traded up $11.32 during trading hours on Monday, hitting $527.36. 2,887,666 shares of the company were exchanged, compared to its average volume of 4,758,233. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $482.38 billion, a PE ratio of 34.00, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a fifty day simple moving average of $508.81 and a 200-day simple moving average of $543.92.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. The business's quarterly revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.59%. UnitedHealth Group's dividend payout ratio is 54.19%.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm's stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Oppenheimer lifted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Finally, Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.